Exploration of 2-benzylbenzimidazole scaffold as novel inhibitor of NF-κB

Add time:07/11/2019    Source:sciencedirect.com

For finding the novel inhibitor of nuclear factor κB activity, a series of benzimidazole derivatives were rationally designed, synthesized and systematically studied for their in vitro activities against LPS induced NF-κB inhibition in RAW 264.7 cells using the SEAP assay based on the flexible chalcone JSH ((E)-1-(2-hydroxy-6-(isopentyloxy)phenyl)-3-(4-hydroxy phenyl)prop-2-en-1-one) which was previously reported. Although most of the benzimidazole derivatives showed strong inhibitory activity in low micromolar potency, 2-(4-methoxybenzyl)-1H-benzo[d]imidazole (3m; IC50 = 1.7 μM) and 2-(2-methoxybenzyl)-1H-benzo[d]imidazole (3n; IC50 = 2.4 μM) showed the best inhibition. The structure activity relationship revealed that 2-benzylbenzimidazole scaffold with hydrogen bonding acceptor on phenyl ring appears as a pharmacophore.

We also recommend Trading Suppliers and Manufacturers of 2-(ISOPENTYLOXY)-5-(TRIFLUOROMETHYL)ANILINE (cas 946682-64-0). Pls Click Website Link as below: cas 946682-64-0 suppliers

Prev:Etilefrine (cas 85750-39-6) and amezinium reduce uterine blood flow of pregnant guinea pigs
Next:Extraction, structural characterization and stability of polyhydroxylated naphthoquinones from shell and spine of New Zealand sea urchin (Evechinus chloroticus))